AbbVie Inc. and Landos Biopharma, Inc.  had announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development of novel, oral therapeutics for patients with autoimmune diseases. Landos’ lead investigational asset…

ONO Pharmaceutical and Deciphera Pharmaceuticals had announced that on April 29, 2024 ,ONO and Deciphera entered into a definitive merger agreement under which ONO will acquire all outstanding shares of Deciphera common stock for US $ 25.60 per share in…